Evidence map›Paper›PMID 41278484›Full record

ArticleGastroenterology research and practice2025

Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study.

Line Graser Jensen, Marie Kjær, Jens Rikardt Andersen

Registry-linked trialAbstract read
In one paragraph

Article in Gastroenterology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05618106 (Modification of the Low FODMAP Diet in Treatment of Irritable Bowel Syndrome), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05618106 nacompletednot on this map

Modification of the Low FODMAP Diet in Treatment of Irritable Bowel Syndrome: A Randomised Cross-over Study

TypeinterventionalSponsorJens Rikardt AndersenRan2019 to 2020Enrolled9ConditionsIrritable Bowel SyndromeArmsLow FODMAP DIET = Diet with Low polyol, FOS and GOS
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Line Graser JensenDepartment of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Marie KjærDepartment of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-7509-8407
Jens Rikardt AndersenDepartment of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.ORCID https://orcid.org/0000-0003-3503-8474

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Irritable bowel syndrome (IBS) can be dietary managed by applying restrictions in the diet of fermentable oligosaccharides, disaccharides, monosaccharides and polyols-the low FODMAP diet. However, many patients have major difficulties integrating the diet into their daily lives. Objective: We aimed to investigate if the three carbohydrate groups eliminated in the traditional low FODMAP diet are equally important in relieving gastrointestinal symptoms in IBS. Methods: Nine patients with IBS according to the Rome IV criteria and referred to specialised diet therapy in private clinics were randomised in a crossover design to three different carbohydrate-modified diets: (A) low polyol diet, (B) low FOS + GOS diet and (C) low standard FODMAP diet for 4 weeks on each diet. Symptoms were assessed by the Birmingham IBS questionnaire and adequate relief (IBS-AR) and quality of life by the IBS Quality of Life Scale questionnaire (IBS-QOL) at baseline and after every intervention period by a dietitian with assessment of the intake by weekly contact. Nonparametric statistical methods were used. Results: Compared to baseline, the low polyol diet did not change the symptoms, but relief was significant on both the low FOS + GOS diet and the low FODMAP diet ( Conclusion: A carbohydrate-modified diet with the exclusion of fructooligosaccharides and galactooligosaccharides (low FOS + GOS diet) reduced gastrointestinal symptoms and improved quality of life equally to the standard low FODMAP diet in patients with IBS. Polyol restriction was of minor importance. The low FOS + GOS diet could be the starting diet in selected patients with IBS. Trial Registration: ClinicalTrials.gov identifier: NCT05618106.

Indexed as

fructooligosaccharidesfructosegalactooligosaccharidesirritable bowel syndromelow FODMAP dietpolyols

Identifiers

PMID41278484
PMCPMC12634161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.